About Centro de Pesquisa Clinica do Brasil
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Allergan
4
Amgen
1
Chinook Therapeutics U.S., Inc.
1
Eli Lilly and Company
1
Estetra
1
Clinical Trials at Centro de Pesquisa Clinica do Brasil
During the past decade, Centro de Pesquisa Clinica do Brasil conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 5 clinical trials were completed, i.e. on
average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
2018-02-01
2020-11-05
Terminated
450
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
2018-01-24
2020-10-30
Terminated
467
Study to Evaluate the Safety and Efficacy of Relamorelin in Participants With Diabetic Gastroparesis Study 02
2018-02-16
2020-07-16
Terminated
311
A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk
2018-11-20
2021-04-22
Completed
2,002
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke
2019-06-11
2025-07-26
Active, not recruiting
12,301
Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort Study I)
2019-12-30
2023-12-01
Recruiting
1,500
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Centro de Pesquisa Clinica do Brasil" #1 sponsor was "Allergan" with 4 trials, followed by "Amgen" with 1 trials
sponsored, "Chinook Therapeutics U.S., Inc." with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "Estetra"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Centro de Pesquisa Clinica do Brasil"
#1 collaborator was "ICON Clinical Research" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Centro de Pesquisa Clinica do Brasil
According to Clinical.Site data, the most researched conditions in "Centro de Pesquisa Clinica do Brasil" are
"Gastroparesis" (4 trials), "Diabetes Mellitus" (3 trials), "Coronary Heart Disease (CHD)" (1 trials), "IgA Nephropathy" (1 trials) and "Immunoglobulin A Nephropathy" (1 trials). Many other conditions were trialed in "Centro de Pesquisa Clinica do Brasil" in a lesser frequency.
Clinical Trials Intervention Types at Centro de Pesquisa Clinica do Brasil
Most popular intervention types in "Centro de Pesquisa Clinica do Brasil" are "Drug" (8 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Relamorelin" (3 trials), "Atrasentan" (1 trials), "Estetrol oral tablet" (1 trials) and "Evolocumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Centro de Pesquisa Clinica do Brasil
The vast majority of trials in "Centro de Pesquisa Clinica do Brasil" are
7 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Centro de Pesquisa Clinica do Brasil
Currently, there are NaN active trials in "Centro de Pesquisa Clinica do Brasil".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Centro de Pesquisa Clinica do Brasil,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Centro de Pesquisa Clinica do Brasil, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".